Gary M. Levin, BA, CTR FCDS Annual Conference 7/26/2017

Similar documents
Translating Medical Claims into Meaningful Cancer Data JUDY BONNER, RN, MS, CTR FLORIDA CANCER DATA SYSTEM ANNUAL MEETING JULY 27, 2016

Florida Cancer Data System STAT File Documentation Version 2019

Estimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.

National Cancer Statistics in Korea, 2014

Cancer in New Mexico 2017

Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts

Cancer in New Mexico 2014

Cancer in Utah: An Overview of Cancer Incidence and Mortality from

*

7/29/2014. FCDS Annual Meeting July 24-25, 2014 Caribe Royale Resort Orlando, Florida

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill

Epidemiology in Texas 2006 Annual Report. Cancer

Welcome ACoS Brainstorming Webinar

Setting the stage for change: upgrading the physician cancer case reporting application in New York

ANNUAL CANCER REGISTRY REPORT-2005

The Cancer Burden in California. Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012

CANCER FACTS & FIGURES For African Americans

Key Words. Cancer statistics Incidence Lifetime risk Multiple primaries Survival SEER

Tumor Comparison. NAACCR Death Clearance Manual Update. Bobbi Jo Matt, BS RHIT CTR NAACCR 2013 Conference, Austin, TX June 12, 2013

S OUTHEAST CANCER C ENTER. Annual Cancer Report 2015

MONTHLY JOURNAL OF UPDATES AND INFORMATION. Revised November 2008 (Additions and revisions appear in bold)

Outcomes Report: Accountability Measures and Quality Improvements

Cancer in Estonia 2014

2016 Cancer Registry Annual Report

DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY

Outcomes Report: Accountability Measures and Quality Improvements

Annual Report to the Nation on the Status of Cancer, , Featuring Survival Questions and Answers

Republican Research and Practical Center for Radiation Medicine and Human Ecology. Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus

Cancer survival in Seoul, Republic of Korea,

American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013

CDC & Florida DOH Attribution

ON-LINE REGISTRATION FCDS MONOGRAPH: 2004 ADMISSIONS (TOTAL), ANALYTIC CASES ONLY FLORIDA ANNUAL CANCER REPORT: 2001 INCIDENCE

LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

Information Services Division NHS National Services Scotland

Cancer survival in Shanghai, China,

Oncology. Cancer Committee Chairman Report Annual Report

Cancer Treatment Centers of America ATLANTA CANCER REGISTRY. Annual Report

APPENDIX ONE: ICD CODES

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

CANCER PROGRAM Annual Report. Cancer Registry Database 2008 CANCER CASES AND BREAST CANCER SITE OUTCOMES ANALYSIS

Chapter II: Overview

National Cancer Institute

2014 CANCER CENTER ANNUAL REPORT

Impact and implications of Cancer Death Status Reporting Delay on Population- Based Relative Survival Analysis with Presumed-Alive Assumption

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I

Annual Report CANCER REGISTRY. at Eastern Regional Medical Center. Cancer Treatment Centers of America. Philadelphia, Pennsylvania.

CDC & Florida DOH Attribution

Cancer survival in Busan, Republic of Korea,

Cancer in Central and South America BOLIVIA

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA

Dx code for breast cancer in remission

NAACCR WEBINAR: ABSTRACTING THYROID/LARYNX CANCER INCIDENCE FLORIDA: PEDIATRIC CANCER ADMISSIONS (TOTAL), ANALYTIC CASES ONLY FCDS REGISTER VOL.

A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files

Cancer survival in Bhopal, India,

2017 CANCER PROGRAM ANNUAL REPORT. Based on 2016 Data

Information Services Division NHS National Services Scotland

Annual Report to the Nation on the Status of Cancer, , with a Special Feature Regarding Survival

PREVIEW OF REGISTRY-SPECIFIC AND AGGREGATED RELATIVE SURVIVAL ESTIMATES IN CANCER IN NORTH AMERICA

Cancer survival in Hong Kong SAR, China,

Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5).

Appendix A: Definitions for Cancer Incidence Data

PROMEDICA MONROE REGIONAL HOSPITAL Annual Report

Overview of 2010 Hong Kong Cancer Statistics

Cancer in Colorado Incidence, Mortality, and Survival

2016 Public Outcomes Report

Annual Report to the Nation on the Status of Cancer, , Featuring the Increasing Incidence of Liver Cancer

What is the Impact of Cancer on African Americans in Indiana? Average number of cases per year. Rate per 100,000. Rate per 100,000 people*

Message from the President & CEO John Solheim, FACHE

Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths

SKCC Protocol Review Committee New Study Application

Cancer Statistics, 2011

2016 ANNUAL REPORT. A Comprehensive Community Cancer Program (CCCP) American College of Surgeons Commission on Cancer

Cancer in Rural Illinois, Incidence, Mortality, Staging, and Access to Care. April 2014

Colorectal Cancer Screening

Suicides increased in 2014

Phase-specific Net Costs of Cancer Care in Ontario. Claire de Oliveira, M.A. PhD

Physician On-line Staging Application. Darlene Dale Head, PMH Cancer Registry

Cancer Incidence and Mortality: District Cancer Registry, Trivandrum, South India

the 2015 Annual Report

Overview of 2013 Hong Kong Cancer Statistics

Subject Cancers in Firefighters and Fire Investigators

1998 FLORIDA ANNUAL CANCER REPORT: Incidence and Mortality

CODING PRIMARY SITE. Nadya Dimitrova

FCDS TENTATIVE V11 TO V11.1 IMPLEMENTATION SCHEDULE

Cancer Program Report 2014

Neoplasms/Lymphoma/Leukemia

Samuel M. Lesko, MD, MPH Director of Research/Medical Director

Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute

Oncology Centre Research Unit TUMOR REGISTRY

TABLE OF CONTENTS. Introduction letter, Dr. Richard Deming. Cancer Center Overview, Tim Hackbart. Overall analytic case distribution

CANCER IN IDAHO 2016 Preliminary

CANCER ANNUAL REPORT Froedtert & The Medical College of Wisconsin Cancer Network at Froedtert Health St. Joseph s Hospital s Kraemer Cancer Center

Phase-specific Costs of Cancer Care in Ontario

Overview FLORIDA CANCER DATA SYSTEM

Evaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials

Cancer Incidence and Mortality in New Jersey

Transcription:

Gary M. Levin, BA, CTR FCDS Annual Conference 7/26/2017 Presentation Overview Background Methods Results Conclusions 2 1

Background Increase physician reporting Capture missing first course treatment Capture missing cases particularly in urological and hematopoietic Reduce burden on physicians to comply 5010/837 reporting data standard Duplicate claims submission and send to registry Process has evolved for almost 5 years 3 Background Received Over 17 Million Claims Primarily Medical Oncologists and Dermatologists Registration of Physician Over 2,000 Physicians Registered Used Florida Licensure and NPI to Identify Mass e mail sent where e mail available EXTREMELY Labor Intensive Statewide Coverage 4 2

Methods Crosswalks, Crosswalks, Crosswalks Claims Coding ICDO3/FORDS ICD9 Diagnosis and Procedure codes ICD10 Diagnosis and Procedure codes starting 10/2015 CPT Current Procedural Terminology HCPCS Healthcare Common Procedure Coding System 5 Methods Diagnosis Code Translation ICD10 Code Description Site Laterality Histology Behavior Grade C50 Malignant neoplasm of breast C50.9 9 8000 3 9 C50.011 Malignant neoplasm of nipple and areola, right female breast C50.0 1 8000 3 9 C50.012 Malignant neoplasm of nipple and areola, left female breast C50.0 2 8000 3 9 C50.019 Malignant neoplasm of nipple and areola, unsp female breast C50.0 9 8000 3 9 C50.021 Malignant neoplasm of nipple and areola, right male breast C50.0 1 8000 3 9 C81 Hodgkin lymphoma C77.9 0 9650 3 9 C81.0 Nodular lymphocyte predominant Hodgkin lymphoma C77.9 0 9659 3 9 C81.00 Nodular lymphocyte predominant Hodgkin lymphoma, unsp site C77.9 0 9659 3 9 C81.02 Nodular lymphocy predom Hodgkin lymphoma, intrathorac nodes C77.1 0 9659 3 9 C81.03 Nodular lymphocyte predom Hodgkin lymphoma, intra abd nodes C77.2 0 9659 3 9 Procedure Code Translation CODE Type Code Description FORDS Code Treatment Type J8520 HCPCS Capecitabine, oral, 150 mg Chemotherapy Treatment J8521 HCPCS Capecitabine, oral, 500 mg Chemotherapy Treatment J8530 HCPCS Cyclophosphamide oral 25 MG Chemotherapy Treatment J8560 HCPCS Etoposide oral 50 MG Chemotherapy Treatment 51720 CPT TREATMENT OF BLADDER LESION 01 Immunotherapy Treatment (BRM) 92.21 ICD 9 SUPERFICIAL RADIATION 20 Radiation Treatment 92.22 ICD 9 ORTHOVOLTAGE RADIATION 21 Radiation Treatment 85.41 ICD 9 UNILAT SIMPLE MASTECTOMY 41 Surgical Treatment of Primary 85.42 ICD 9 BILAT SIMPLE MASTECTOMY 42 Surgical Treatment of Primary 6 3

Methods Rules, Rules, Rules Hold Claims Abstracts for 18 months Before Processing Allow time to receive all claims Allow time to match against most complete curated abstracts Determine First Course Therapy Breast and Prostate up to 1 Year All Other Sites up to 8 months 7 Methods Leverage Florida Automation Patient/Tumor Linkages Patient/Tumor Consolidation Process Create Claims Based Abstracts (Crosswalks, Linkage, Consolidation) Apply All Timing Rules Link Claims Abstract Against Main Database 8 4

Results Treatment Enhancing Abstracts Patient/Tumor Linked Successfully Shadow image of consolidated Patient and Tumor data Overlay all treatment information gleaned from claims Process, link and consolidate according to routine process Improves First Course Therapy Date of Last Contact set to highest claims date 9 Results Treatment Enhancing Abstracts Dx Year Chemo Surgery Radiation Hormone BRM 2010 1,298 0 6 73 4 2011 3,141 2 81 159 10 2012 3,481 20 409 257 101 2013 6,417 134 1,307 842 706 2014 8,158 181 1,953 1,239 1,177 2015 5,957 64 1,367 796 991 Total 28,452 401 5,123 3,366 2,989 Processed 54,163 Enhancements 40,331 10 5

Results Treatment Enhancing Abstracts Chemo Improvement By Site Count Lung and Bronchus 7,782 Breast 6,830 Pancreas 1,617 Non Hodgkin Lymphoma Nodal 1,440 Rectum 1,031 Myeloma 825 Esophagus 752 Ovary 638 Urinary Bladder 630 Sigmoid Colon 582 Radiation Improvement by Site Count Prostate 2,217 Breast 1,007 Lung and Bronchus 814 Rectum 179 Esophagus 78 Brain 74 Cervix Uteri 65 Anus, Anal Canal and Anorectum 64 Larynx 63 Corpus Uteri 57 11 Results New Incidence Abstracts Claims Abstracts Not Matching Database Link claims abstract to Pathology Reports Visual Review (Labor Intensive) Create case finding abstracts Link to existing cases (missed automated linkage) Send case to physician for follow back Mark as non cancer/non reportable case 12 6

Results New Incidence Abstracts 13 Results New Incidence Abstracts 14 7

Results New Incidence Abstracts Dx Year New Cases 2010 768 2011 5,968 2012 3,359 2013 8,400 2014 7,271 2015 9,455 Total 35,221 New Case by Site New Cases Miscellaneous Heme/Lymph Malignancies 16,944 Non Hodgkin Lymphoma Extranodal 4,729 Chronic Lymphocytic Leukemia 3,933 Myeloma 2,192 Aleukemic, subleukemic and NOS 1,610 Non Hodgkin Lymphoma Nodal 1,084 Breast 1,021 Chronic Myeloid Leukemia 889 Acute Myeloid Leukemia 539 Other Lymphocytic Leukemia 472 Urinary Bladder 258 Melanoma of the Skin 252 Prostate 228 15 Results New Incidence Abstracts Next Steps Residence Validation Work with Lexis/Nexis on Residence Histories Send All Non Confirmed Florida Residence Abstracts Compare Residence History and Diagnosis Dates Verified Florida Case Process Abstract Not Verified Follow Back to Physician Extra step needed due to snowbird influence 16 8

Conclusions More Complete Treatment Improve case reporting particularly: Hematopoietic Cancers Urinary Cancers Case Finding is Resource Intensive 17 Conclusions Potential Opportunities for Researchers View Patient longitudinally Second through N course of treatment Detailed Medications Limitations: No Orals Ordered Not Actual Dose Comorbid Conditions Non Cancer Procedures/Non Cancer Treatments 18 9

Conclusions ACOS Hospital Follow Up Improved Vital Status Improved Treatment Information (particularly Chemo) Improved Date of Last Contact Included in the FCDS IDEA Facility Follow Up System 19 Acknowledgements Dr. Lynne Penberthy, MD, MPH Dr. Jill MacKinnon, PhD, CTR FCDS Claims Processing Workgroup Meg Herna, BA, CTR Steve Peace, BS, CTR Wendy Scharber, RHIT, CTR Monique Hernandez, PhD Judith Bonner, MS, RN, CTR Paul Stearns (Software Contractor) Translation Tables Validation Team Collaborative Effort Florida Cancer Data System Virginia Cancer Registry NCI SEER CDC NPCR 20 10

Thank You 21 11